Lamotrigine and hemophagocytic lymphohistiocytosis

Affiliations

¹ From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University School of Medicine, Palo Alto, CA; and the School of Pharmacy and Department of Neurology (B.E.G.), University of Wisconsin, Madison. kmeador@stanford.edu.
² From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University School of Medicine, Palo Alto, CA; and the School of Pharmacy and Department of Neurology (B.E.G.), University of Wisconsin, Madison.

Editorial

Kimford J Meador et al. Neurology. 2019.

. 2019 May 21;92(21):979-980.

doi: 10.1212/WNL.0000000000007518. Epub 2019 Apr 17.

¹ From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University School of Medicine, Palo Alto, CA; and the School of Pharmacy and Department of Neurology (B.E.G.), University of Wisconsin, Madison. kmeador@stanford.edu.
² From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University School of Medicine, Palo Alto, CA; and the School of Pharmacy and Department of Neurology (B.E.G.), University of Wisconsin, Madison.

No abstract available

Comment on

Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine.
Kim T, Kulick CG, Kortepeter CM, Brinker A, Waldron P. Kim T, et al. Neurology. 2019 May 21;92(21):e2401-e2405. doi: 10.1212/WNL.0000000000007517. Epub 2019 Apr 17. Neurology. 2019. PMID: 30996059